Literature DB >> 25417786

PD0332991 (palbociclib) for treatment of pediatric intracranial growing teratoma syndrome.

Kris Ann P Schultz1, Joseph Petronio, Anne Bendel, Richard Patterson, David J Vaughn.   

Abstract

Growing teratoma syndrome is characterized by growth of mature teratoma elements of a mixed germ cell tumor despite resolution of immature/malignant elements with administration of chemotherapy. Surgical resection is the only known cure for growing teratoma syndrome but in the brain, complete resection may be impossible. In these instances, mature teratoma, although histologically benign, may be fatal. In this report, we present the case of a child with a large, rapidly growing, unresectable pineal region growing teratoma. PD0332991 was administered with stabilization of the solid, enhancing components of the mass. Minimal adverse effects were noted.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  brain tumor; cyclin-dependent kinase; germ cell tumor; teratoma

Mesh:

Substances:

Year:  2014        PMID: 25417786     DOI: 10.1002/pbc.25338

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  8 in total

1.  p16 Loss and E2F/cell cycle deregulation in infant posterior fossa ependymoma.

Authors:  Seth C Lummus; Andrew M Donson; Katherine Gowan; Kenneth L Jones; Rajeev Vibhakar; Nicholas K Foreman; B K Kleinschmidt-DeMasters
Journal:  Pediatr Blood Cancer       Date:  2017-05-26       Impact factor: 3.167

2.  Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.

Authors:  Carl Koschmann; Yi-Mi Wu; Chandan Kumar-Sinha; Robert Lonigro; Pankaj Vats; Katayoon Kasaian; Marcin Cieslik; Xuhong Cao; Bailey Anderson; Kevin Frank; Lili Zhao; John R Prensner; Andrew H Zureick; Jessica Everett; Brendan Mullan; Bernard Marini; Sandra Camelo-Piragua; Sriram Venneti; Paul McKeever; Kathryn McFadden; Andrew P Lieberman; Marcia Leonard; Cormac O Maher; Hugh Garton; Karin Muraszko; Patricia Robertson; Dan Robinson; Arul M Chinnaiyan; Rajen Mody
Journal:  JCO Precis Oncol       Date:  2018-05-04

Review 3.  Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.

Authors:  Neha S Mangini; Robert Wesolowski; Bhuvaneswari Ramaswamy; Maryam B Lustberg; Michael J Berger
Journal:  Ann Pharmacother       Date:  2015-08-31       Impact factor: 3.154

4.  Pediatric Ovarian Growing Teratoma Syndrome.

Authors:  Rebecca M Rentea; Aaron Varghese; Atif Ahmed; Alexander Kats; Michelle Manalang; Tazim Dowlut-McElroy; Richard J Hendrickson
Journal:  Case Rep Surg       Date:  2017-06-01

5.  Growing Teratoma Syndrome Secondary to Ovarian Giant Immature Teratoma in an Adolescent Girl: A Case Report and Literature Review.

Authors:  Song Li; Zhenzhen Liu; Chengyong Dong; Fei Long; Qinlong Liu; Deguang Sun; Zhenming Gao; Liming Wang
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

6.  Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant.

Authors:  Timothy F Tramontana; Mark S Marshall; Amy E Helvie; Morgan R Schmitt; Jennifer Ivanovich; Jacquelyn L Carter; Jamie L Renbarger; Michael J Ferguson
Journal:  JCO Precis Oncol       Date:  2020-04-30

7.  EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults.

Authors:  Didier Frappaz; Girish Dhall; Matthew J Murray; Stuart Goldman; Cecile Faure Conter; Jeffrey Allen; Rolf Dieter Kortmann; Daphne Haas-Kogen; Giovanni Morana; Jonathan Finlay; James C Nicholson; Ute Bartels; Mark Souweidane; Stefan Schönberger; Alexandre Vasiljevic; Patricia Robertson; Assunta Albanese; Claire Alapetite; Thomas Czech; Chin C Lau; Patrick Wen; David Schiff; Dennis Shaw; Gabriele Calaminus; Eric Bouffet
Journal:  Neuro Oncol       Date:  2022-04-01       Impact factor: 13.029

Review 8.  Treating cancer with selective CDK4/6 inhibitors.

Authors:  Ben O'Leary; Richard S Finn; Nicholas C Turner
Journal:  Nat Rev Clin Oncol       Date:  2016-03-31       Impact factor: 66.675

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.